翻訳と辞書 |
Iranian National Formulary : ウィキペディア英語版 | Iranian National Formulary
The Iranian National Formulary (INF) has more than 2,300 molecules registered at the Iran's Ministry of Health, including various strengths and dosage forms. The standards regarding pharmaceutical products in Iran are determined and modified by the ''Pharmacopeia Council''. Iran has adopted a full generic-based National Drug Policy (NDP), with local production of essential drugs and vaccines as one of the main goals. 〔https://web.archive.org/web/20070306004716/http://www.austrade.gov.au/Health-services-and-pharmaceuticals-to-Iran/default.aspx〕 Formalities for approval of a new molecule can take between 1 month and 12 months (maximum), as follows: # 1 month: for new strength/dosage form of any registered/approved product; # 3 to 7 months: for any new product to the INF list. ==Top 20 drug molecules and sales in Iran==
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Iranian National Formulary」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|